Opioid peptides inhibit the action of oestradiol on human myometrial cells in culture

Molecular Human Reproduction

Volumn 5, Issue 6, 1999, Pages 565-572

  Kornyei J L ^a   Vertes Z ^a   Oszter, A ^a   Kovacs K A ^a   Rao, Ch V ^b   Vertes M ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b University of Louisville School of Medicine   (United States)

Author keywords

Human; Oestradiol; Opiates; Proliferation; Uterus

Indexed keywords

ENKEPHALINAMIDE DERIVATIVE; ESTRADIOL; NALOXONE; OPIATE PEPTIDE; PROGESTERONE;

ARTICLE; CELL CULTURE; CELL DENSITY; CELL PROLIFERATION; CONTROLLED STUDY; ESTROGEN RELEASE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MYOMETRIUM; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER;

ADULT; CELL DIVISION; CELLS, CULTURED; DYNORPHINS; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALIN, METHIONINE; ENKEPHALINS; ESTRADIOL; FEMALE; HUMANS; INHIBITORY CONCENTRATION 50; MUSCLE, SMOOTH; MYOMETRIUM; NALOXONE; NARCOTIC ANTAGONISTS; PROGESTERONE;

EID: 0344689843     PISSN: 13609947     EISSN: None     Source Type: Journal    
DOI: 10.1093/molehr/5.6.565     Document Type: Article

References (61)

1. Aronica, S.M. and Katzenellenbogen, B.S. (1993) Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-1. Mol. Endocrinol., 7, 743-752.
2. Aronica, S.M., Kraus, W.L. and Katzenellenbogen, B.S. (1994) Estrogen action via the cAMP signaling pathway: Stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc. Natl. Acad. Sci. USA, 91, 8517-8521.
3. Astrahantseff, K.N. and Morris, J.E. (1994) Estradiol-17 beta stimulates proliferation of uterine epithelial cells cultured with stromal cells but not cultured separately. In Vitro Cell. Dev. Biol. (Animal), 30, 769-776.
4. Baraldi, M., Giarré, G., Santi, M. et al. (1985) Pregnancy related changes of opiate receptors identified in rat uterine membranes by 3H-naloxone binding. Peptides, 6, 971-974.
5. Belcheva, M., Barg, J., Rowinski, J. et al. (1993) Novel opioid binding sites associated with nuclei of NG108-15 neurohybrid cells. J. Neurosci., 13, 104-114.
6. Borras, M., Hardy, L., Lempereur, F. et al. (1994) Estradiol-induced down-regulation of estrogen receptor - effect of various modulators of protein synthesis and expression. J. Steroid Biochem. Mol. Biol., 48, 325-336.
7. Burton, K. (1956) A study of the condition and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem. J., 62, 315-323.
8. Cooke, P.S., Buchanan, D.L., Young, P. et al. (1997) Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium. Proc. Natl. Acad. Sci. USA, 94, 6535-6540.
9. Couse, J.F., Lindzey, J., Grandien, K. et al. (1997) Tissue distribution and quantitative analysis of estrogen receptor-alpha (ER alpha) and estrogen receptor-beta (ER beta) messenger ribonucleic acid in the wild-type and ER alpha-knockout mouse. Endocrinology, 138, 4613-4621.
10. Douglass, J., Cox, B., Quinn, B. et al. (1987) Expression of the prodynorphin gene in male and female mammalian reproductive tissues. Endocrinology, 120, 707-713.
11. Dowdy, S. and Wearden, S. (1983) Statistics for Research. John Wiley & Sons Inc., New York, USA.
12. Enmark, E., Peltohuikko, M., Grandien, K. et al. (1997) Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. J. Clin. Endocrinol. Metab., 82, 4258-4265.
13. 2+ uptake in uterine strips from ovariectomized rats. Prostagland. Leuk. Essent. Fatty Acids., 47, 29-33.
14. Fukamachi, H. and McLachlen, J.A. (1991) Proliferation and differentation of mouse uterine epithelial cells in primary serum-free culture: estradiol-17 beta suppresses uterine epithelial proliferation cultured on a basement membrane-like substratum. In Vitro Cell. Dev. Biol. 27, 907-913.
15. Gangula, P.R.R., Dong, Y.L. and Yallampalli, C. (1997) Rat myometrial smooth muscle cells express endothelial nitric oxide synthase. Hum. Reprod., 12, 561-568.
16. 3H-oestradiol to nuclear type II binding sites of rat uterus and hypothalamus. J. Steroid Biochem. Mol. Biol., 32, 433-438.
17. Graham, J.D. and Clarke, C.L. (1997) Physiological action of progesterone in target tissues. Endocr. Rev., 18, 502-519.
18. Hatzoglou, A., Bakogeorgou, E. and Castanas, E. (1996) The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors. Eur. J. Pharmacol. Mol. Pharm., 296, 199-207.
19. Jin, D.F., Muffly, K.E., Okulicz, W.C. et al. (1988) Estrous-cycle- and pregnancy-related differences in expression of the proenkephalin and proopiomelanocortin genes in the ovary and uterus. Endocrinology, 122, 1466-1471.
20. Kimball, C.D., Chang, C.M. and Chapman, M.B. (1984) Endogenous opioid peptides in intrapartum uterine blood. Am. J. Obstet. Gynecol., 149, 79-82.
21. Környei, J. (1987) Hormon-receptor kötödés jellegzetességeinek vizsgálata. Investigation of hormone-receptor binding. Laboratóriumi Diagnosztika (Lab. Diagn. Hungary), 14, 221-226.
22. Környei, J.L., Lei, Z.M. and Rao, C.V. (1993) Human myometrial smooth muscle cells are novel targets of direct regulation by human chorionic gonadotropin. Biol. Reprod., 49, 1149-1157.
23. Környei, J.L., Vértes, Z., Oszter, A. et al. (1997) Opioid peptides inhibit the estradiol-induced proliferation of cultured rat uterine cells. Eur. J. Pharmacol., 336, 65-70.
24. Kraus, W.L., Weis, K.E. and Katzenellenbogen, B.S. (1997) Determinants for the repression of estrogen receptor transcriptional activity by ligand-occupied progestin receptors. J. Steroid Biochem. Mol. Biol., 63, 175-188.
25. Kuiper, G.G. and Gustafsson, J.A. (1997) The novel estrogen receptor-beta subtype: potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens. FEBS Lett., 410, 87-90.
26. Li, W.I., Sung, L.C. and Bazer, F.W. (1991) Immunoreactive methionin-enkephalin secretion by porcine uterus. Endocrinology, 128, 21-26.
27. Low, K.G., Nielsen, C.P., West, N.B. et al. (1989) Proenkephalin gene expression in the primate uterus: regulation by estradiol in the endometrium. Mol. Endocrinol., 3, 852-857.
28. Lowry, O.H., Rosebrough, N.J., Farr, A.L. et al. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275.
29. Maneckjee, R., Biswas, R. and Vonderhaar, B.K. (1990) Binding of opioids to human MCF-7 breast cancer cells and their effects on growth. Cancer Res., 50, 2234-2238.
30. Mansour, A., Watson, S.J. and Akil, H. (1995) Opioid receptors: Past, present and future. Trends Neurosci., 18, 69-70.
31. McDonnell, D.P., Vegeto, E. and Omalley, B.W. (1992) Identification of a negative regulatory function for steroid receptors. Proc. Natl. Acad. Sci. USA, 89, 10563-10567.
32. Mosselman, S., Polman, J. and Dijkema, R. (1996) ER beta: Identification and characterization of a novel human estrogen receptor. FEBS Lett., 392, 49-53.
33. Muffly, K.E., Jin, D.F., Okulicz, W.C. et al. (1988) Gonadal steroids regulate proenkephalin gene expression in a tissue-specific manner within the female reproductive system. Mol. Endocrinol., 2, 979-984.
34. Nardulli, A.M. and Katzenellenbogen, B.S. (1986) Dynamics of estrogen receptor turnover in uterine cells in vitro and in uteri in vivo. Endocrinology, 119, 2038-2046.
35. Ördög, T., Vértes, Z. and Vértes, M. (1992) Inhibition of oestradiol-induced DNA synthesis by opioid peptides in the rat uterus. Life Sci., 51, 1187-1196.
36. Ördög, T., Vértes, Z. and Vértes, M. (1993) Role of endogenous opioids in progesterone antagonism on oestradiol induced DNA synthesis in the rat uterus. J. Steroid Biochem. Mol. Biol., 45, 455-457.
37. Ogawa, S., Inoue, S., Watanabe, T. et al. (1998) The complete primary structure of human estrogen receptor beta (hER beta) and its heterodimerization with ER alpha in vivo and in vitro. Biochem. Biophys. Res. Commun., 243, 122-126.
38. Ohia, S.E. and Laniyonu, A.A. (1989) Naloxone-insensitive inhibitory and excitatory effects of opioid agonists in the rat isolated uterus. J. Pharm. Pharmacol., 41, 168-172.
39. Pace, P., Taylor, J., Suntharalingam, S. et al. (1997) Human estrogen receptor beta binds DNA in a manner similar to and dimerizes with estrogen receptor alpha. J. Biol. Chem., 272, 25832-25838.
40. Pettersson, K., Grandien, K., Kuiper, G.G.J.M. et al. (1997) Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha. Mol. Endocrinol., 11, 1486-1496.
41. Poli, E., Merialdi, A. and Coruzzi, G. (1990) Characterization of the spontaneous motor activity of the isolated human pregnant myometrium. Pharmacol. Res., 22, 115-124.
42. Revelli, A., Massobrio, M. and Tesarik, J. (1998) Nongenomic actions of steroid hormones in reproductive tissues. Endocr. Rev., 19, 3-17.
43. 5-enkephalinamide. J. Pharm. Pharmacol., 33, 534-535.
44. Rossi, M.J., Chegini, N. and Masterson, B.J. (1992) Presence of epidermal growth factor, platelet-derived growth factor, and their receptors in human myometrial tissue and smooth muscle cells: their action in smooth muscle cells in vitro. Endocrinology, 130, 1716-1727.
45. Saatcioglu, F., Claret, F.X. and Karin, M. (1994) Negative transcriptional regulation by nuclear receptors. Semin. Cancer Biol., 5, 347-359.
46. Satoh, M. and Minami, M. (1995) Molecular pharmacology of the opioid receptors. Pharmacol. Ther., 68, 343-364.
47. Savouret, J.F., Chauchereau, A., Misrahi, M. et al. (1994) The progesterone receptor. Biological effects of progestins and antiprogestins. Hum. Reprod., 9 (Suppl.), 7-11.
48. Schatz, R., Soto, A.M. and Sonnenschein, C. (1984) Estrogen-induced cell multiplication: direct or indirect effect on rat uterine cells? Endocrinology, 115, 501-506.
49. Szücs, M., Bem, W.T., Yeung, S.C.J. et al. (1990) Characterization of intracellular opioid binding sites and G regulatory proteins in neonatal and adult rat brain. Eur. J. Pharmacol., 183, 2311.
50. Tong, W.D., Perkins, R., Xing, L. et al. (1997) QSAR models for binding of estrogenic compounds to estrogen receptor alpha and beta subtypes. Endocrinology, 138, 4022-4025.
51. Vértes, M., Pámer, Z. and Garai, J. (1986) On the mechanism of opioid-oestradiol interactions. J. Steroid Biochem. Mol. Biol., 24, 235-238.
52. Vértes, Z., Melegh, G., Vértes, M. et al. (1982) Effect of naloxone and D-met2-pro5-enkephalinamide treatment on the DNA synthesis in the developing rat brain. Life Sci., 31, 49-54.
53. Vértes, Z., Ördög, T., Vértes, M. et al. (1993) Changes of 3H-naloxone binding in oestroaen stimulated rat uterus. J. Steroid Biochem. Mol. Biol., 46, 819-825.
54. Vértes, Z., Környei, J.L., Kovács, S. et al. (1995a) Nuclear [H-3]naloxone binding in rat hypothalamus. Neuroreport, 6, 2385-2388.
55. Vértes, Z., Környei, J.L., Kovács, S. et al. (1995b) Role of opioid peptides in the regulation of DNA synthesis in immature rat uterus. Eur. J. Pharmacol. Mol. Pharm., 291, 115-120.
56. Vértes, Z., Környei, J.L., Kovács, S. et al. (1996) Opioids regulate cell proliferation in the developing rat uterus: effects during the period of sexual maturation. J. Steroid Biochem. Mol. Biol., 59, 173-178.
57. Wahlstrom, T., Laatikainen, T., Salminen, K. et al. (1985) Immunoreactive β-endorphin is demonstrable in the secretory but not in the proliferative endometrium. Life Sci., 36, 987-990.
58. Wittert, G., Hope, P. and Pyle, D. (1996) Tissue distribution of opioid receptor gene expression in the rat. Biochem. Biophys. Res. Commun., 218, 877-881.
59. Yen, P.M. and Chin, W.W. (1994) Minireview: Molecular mechanisms of dominant negative activity by nuclear hormone receptors. Mol. Endocrinol., 8, 1450-1454.
60. Zagon, I.S. and McLaughlin, P.J. (1991) Zeta, a growth-related opioid receptor in developing rat cerebellum: identification and characterization. Brain Res., 551, 28-35.
61. Zhu, Y. and Pintar, J.E. (1998) Expression of opioid receptors and ligands in pregnant mouse uterus and placenta. Biol. Reprod., 59, 925-932.